 |
|
|
 | Sequenom Inc (NASDAQ GM:SQNM) | 9:53 AM ET |  |
| TUESDAY, FEBRUARY 09, 2010 | | 8:30 AM | Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test - PR Newswire |  | | THURSDAY, FEBRUARY 04, 2010 | | 8:30 AM | Sequenom Announces Launch of SensiGene Fetal RHD Genotyping Test - PR Newswire |  | | FRIDAY, JANUARY 29, 2010 | | 7:51 AM | Sequenom Inc adds Dr. Wolfgang Holzgreve to its Clinical Advisory Board - M2 |  | | THURSDAY, JANUARY 28, 2010 | | 4:05 PM | Sequenom Announces Addition to Clinical Advisory Board - PR Newswire |  | | FRIDAY, JANUARY 15, 2010 | | 8:30 AM | Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit - PR Newswire |  | | THURSDAY, DECEMBER 17, 2009 | | 7:30 AM | Xenomics' Preliminary Investigation Leads the Company to Believe Sequenom Willfully Manipulated its Down Syndrome Data in its Presentations - BusinessWire |  | | WEDNESDAY, DECEMBER 16, 2009 | | 8:30 AM | Sequenom Appoints Two New Board Members - PR Newswire |  | | THURSDAY, DECEMBER 03, 2009 | | 8:00 AM | Sequenom Announces New Clinical Advisory Board Member - PR Newswire |  |
|
|
 |